FIELD: medicine.
SUBSTANCE: invention concerns pharmaceutical compositions for delivery of the pharmaceutical agent to the centre of disease at the person. The composition contains the pharmaceutical agent and in quality of a pharmaceutically comprehensible carrier albumin where the relation of albumin to the pharmaceutical agent makes less than 9:1. The compositions can additionally contain deferoxamine. The compositions are intended for parenteral or other internal application.
EFFECT: reduction of some undesirable by-effects at comparison with accessible preparations of similar medical products.
120 cl, 5 tbl, 51 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITIONS AND METHODS OF DELIVERY OF PHARMACOLOGICAL AGENTS | 2009 |
|
RU2522977C2 |
| PURIFIED THERAPEUTIC NANOPARTICLES AND METHODS FOR PRODUCTION THEREOF | 2015 |
|
RU2706735C2 |
| PHARMACEUTICAL ANTITUMORAL COMPOSITION OF PACLITAXEL WITH HISTONE N1.3 AS A CARRIER AND A METHOD FOR PREPARING THE COMPOSITION | 2017 |
|
RU2669937C1 |
| COMPOSITIONS, INCLUDING POORLY SOLUBLE IN WATER PHARMACEUTIC SUBSTANCES AND ANTIMICROBIAL SUBSTANCES | 2006 |
|
RU2433818C2 |
| TAXANES COVALENTLY BONDED WITH HYALURONIC ACID OR HYALURONIC ACID DERIVATIVES | 2003 |
|
RU2384593C2 |
| PACLITAXEL-BASE MEDICINAL AGENT STABILIZED WITH ALBUMIN FOR TREATMENT OF SOLID TUMOR | 2001 |
|
RU2270003C2 |
| PHARMACEUTICAL COMPOSITION FOR CHEMOTHERAPY OF ONCOLOGICAL DISEASES AND METHOD OF ITS PREPARATION | 2016 |
|
RU2617511C1 |
| STABLE EMULSION FOR PARENTERAL INTRODUCTION OF BADLY SOLUBLE IN WATER COMPOUNDS, WHICH HAVE ANTI-TUMOR ACTIVITY, AND METHOD OF ITS OBTAINING | 2007 |
|
RU2370261C2 |
| COMPOSITION AND METHOD FOR PRODUCTION OF ENHANCED STABILITY MEDICATIONS SLIGHTLY SOLUBLE IN WATER | 2006 |
|
RU2451510C2 |
| COMBINATION AND METHODS FOR INTRODUCING THERAPEUTIC AGENTS AND COMBINED THERAPY | 2006 |
|
RU2452482C2 |
